Gene expression signature of atypical breast hyperplasia and regulation by SFRP1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gene expression signature of atypical breast hyperplasia and regulation by SFRP1

Published:2019-06-27 Issue:1 Volume:21 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Gregory Kelly J.,Roberts Amy L.,Conlon Erin M.,Mayfield Jacob A.,Hagen Mary J.,Crisi Giovanna M.,Bentley Brooke A.,Kane Jeffrey J.,Makari-Judson Grace,Mason Holly S.,Yu Jun,Zhu Lihua Julie,Simin Karl,Johnson Jacob P. S.,Khan Ashraf,Schneider Ben R.,Schneider Sallie S.,Jerry D. Joseph^ORCID

Funder

National Institute of Environmental Health Sciences

U.S. Department of Defense

Rays of Hope

University of Massachusetts Medical School

Avon Foundation for Women

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-019-1157-5.pdf

Reference70 articles.

1. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25(19):2671–7.

2. Kader T, Hill P, Rakha EA, Campbell IG, Gorringe KL. Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape. Breast Cancer Res. 2018;20(1):39.

3. Tice JA, O'Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst. 2013;105(14):1043–9.

4. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL 3rd, et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: preventing breast cancer. Cancer Prev Res. 2010;3(6):696–706.

5. Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, et al. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med. 2011;364(25):2381–91.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Withaferin-A and Propolis Combinational Drug Therapy for Breast Cancer: An In Vivo Interpretation for Validating the Antiproliferative Efficacy and Ameliorative Potential in Benzo[a]pyrene-Induced Breast Metastasis;Journal of Chemistry;2024-05-14

2. SFRP1 decreases WNT-Mediated M2 macrophage marker expression in breast tissue;Cancer Immunology, Immunotherapy;2024-03-30

3. SFRP1 Decreases Wnt-Mediated M2 Macrophage Marker Expression in Breast Tissue;2023-12-13

4. Changes in mRNA expression of oncogenesis driver genes in atypical ductal breast hyperplasia;Tumors of female reproductive system;2023-11-15

5. Xiaozheng pill exerts an anti-mammary hyperplasia effect through Raf/ERK/ELK and HIF-1α/bFGF pathways;Journal of Traditional and Complementary Medicine;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3